3.0k views
2 votes
The USP-NF can be used to look up:

Select one:
A) Generic substitution availability
B) A side-by-side comparison of medications
C) A medication by its imprint code and color
D) Materials needed for compounding medications

User Voriki
by
9.2k points

2 Answers

3 votes

Final answer:

The USP-NF can be used to look up generic substitution availability.

Step-by-step explanation:

The USP-NF can be used to look up Generic substitution availability. The USP-NF, or United States Pharmacopeia - National Formulary, is a reference book that provides information on drug standards, including generic drug substitution. It contains monographs for drugs, which include information on their identification, strength, dosage forms, and more.

User Axi
by
7.8k points
5 votes

Final answer:

The USP-NF is used to look up materials needed for compounding medications, providing standards for a variety of pharmaceutical needs. The correct answer is option D) Materials needed for compounding medications.

Step-by-step explanation:

The USP-NF (United States Pharmacopeia-National Formulary) can be used to look up D) materials needed for compounding medications.

This is essential for pharmacists who prepare compounded medications, as they must ensure the compatibility of compounds within the same dosing solution. The USP-NF provides standards for medicines, dosage forms, drug substances, excipients, medical devices, and dietary supplements.

When it comes to generic drugs, the U.S. Food and Drug Administration (FDA) requires that a generic drug be interchangeable with or therapeutically equivalent to the brand-name original. An Abbreviated New Drug Application (ANDA) is necessary for the approval of a generic drug. It’s also noteworthy that while the USP-NF is a critical resource for drug standards and pharmacopeial information, it doesn't facilitate generic substitution or provide a side-by-side comparison of medications, nor is it a resource for identifying a medication by its imprint code and color.

User Ebosi
by
7.8k points